1
|
Neal KR, Hebden J and Spiller R:
Prevalence of gastrointestinal symptoms six months after bacterial
gastroenteritis and risk factors for development of the irritable
bowel syndrome: postal survey of patients. BMJ. 314:779–782. 1997.
View Article : Google Scholar
|
2
|
Drossman DA, Li Z, Andruzzi E, et al: U.S.
householder survey of functional gastrointestinal disorders.
Prevalence, sociodemography, and health impact. Dig Dis Sci.
38:1569–1580. 1993. View Article : Google Scholar : PubMed/NCBI
|
3
|
Dean BB, Aguilar D, Barghout V, et al:
Impairment in work productivity and health-related quality of life
in patients with IBS. Am J Manag Care. 11(Suppl 1): S17–S26.
2005.PubMed/NCBI
|
4
|
El-Serag HB: Impact of irritable bowel
syndrome: prevalence and effect on health-related quality of life.
Rev Gastroenterol Disord. 3(Suppl 2): S3–S11. 2003.PubMed/NCBI
|
5
|
El-Serag HB, Olden K and Bjorkman D:
Health-related quality of life among persons with irritable bowel
syndrome: a systematic review. Aliment Pharmacol Ther.
16:1171–1185. 2002. View Article : Google Scholar
|
6
|
Longstreth GF, Bolus R, Naliboff B, et al:
Impact of irritable bowel syndrome on patients’ lives: development
and psychometric documentation of a disease-specific measure for
use in clinical trials. Eur J Gastroenterol Hepatol. 17:411–420.
2005.
|
7
|
Hulisz D: The burden of illness of
irritable bowel syndrome: current challenges and hope for the
future. J Manag Care Pharm. 10:299–309. 2004.PubMed/NCBI
|
8
|
Pace F, Molteni P, Bollani S, et al:
Inflammatory bowel disease versus irritable bowel syndrome: a
hospital-based, case-control study of disease impact on quality of
life. Scand J Gastroentrol. 38:1031–1038. 2003. View Article : Google Scholar : PubMed/NCBI
|
9
|
Kanazawa M, Palsson OS, Thiwan SI, et al:
Contributions of pain sensitivity and colonic motility to IBS
symptom severity and predominant bowel habits. Am J Gastroenterol.
103:2550–2561. 2008. View Article : Google Scholar : PubMed/NCBI
|
10
|
Olszewski PK, Grace MK, Fard SS, et al:
Central nociceptin/orphanin FQ system elevates food consumption by
both increasing energy intake and reducing aversive responsiveness.
Am J Physiol Regul Integr Comp Physiol. 299:R655–R663. 2010.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Przydzial MJ and Heisler LK:
Nociceptin/orphanin FQ peptide receptor as a therapeutic target for
obesity. Mini Rev Med Chem. 8:796–811. 2008. View Article : Google Scholar : PubMed/NCBI
|
12
|
Matsushita H, Ishihara A, Mashiko S, et
al: Chronic intracerebroventricular infusion of nociceptin/orphanin
FQ produces body weight gain by affecting both feeding and energy
metabolism in mice. Endocrinology. 150:2668–2673. 2009. View Article : Google Scholar : PubMed/NCBI
|
13
|
Agostini S, Eutamene H, Broccardo M, et
al: Peripheral anti-nociceptive effect of nociceptin/orphanin FQ in
inflammation and stress-induced colonic hyperalgesia in rats. Pain.
141:292–299. 2009. View Article : Google Scholar : PubMed/NCBI
|
14
|
Drossman DA and Dumitrascu DL: Rome III:
New standard for functional gastrointestinal disorders. J
Gastrointestin Liver Dis. 15:237–241. 2006.
|
15
|
Bunzow JR, Saez C, Mortrud M, et al:
Molecular cloning and tissue distribution of a putative member of
the rat opioid receptor gene family that is not a mu, delta or
kappa opioid receptor type. FEBS Lett. 347:284–288. 1994.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Mogil JS and Pasternak GW: The molecular
and behavioral pharmacology of the orphanin FQ/nociceptin peptide
and receptor family. Pharmacol Rev. 53:381–415. 2001.PubMed/NCBI
|
17
|
Anton B, Fein J, To T, Li X, Silberstein L
and Evans CJ: Immunohistochemical localization of ORL-1 in the
central nervous system of the rat. J Comp Neurol. 368:229–251.
1996. View Article : Google Scholar : PubMed/NCBI
|
18
|
Florin S, Leroux-Nicollet I, Meunier JC
and Costentin J: Autoradiographic localization of [3H]
nociceptin binding sites from telencephalic to mesencephalic
regions of the mouse brain. Neurosci Lett. 230:33–36. 1997.
|
19
|
Wang JB, Johnson PS, Imai Y, et al: cDNA
cloning of an orphan opiate receptor gene family member and its
splice variant. FEBS Lett. 348:75–79. 1994. View Article : Google Scholar : PubMed/NCBI
|
20
|
Nothacker HP, Reinscheid RK, Mansour A, et
al: Primary structure and tissue distribution of the orphanin FQ
precursor. Proc Natl Acad Sci USA. 93:8677–8682. 1996. View Article : Google Scholar : PubMed/NCBI
|
21
|
Mollereau C, Simons MJ, Soularue P, et al:
Structure, tissue distribution, and chromosomal localization of the
prepronociceptin gene. Proc Natl Acad Sci USA. 93:8666–8670. 1996.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Calo’ G, Guerrini R, Rizzi A, Salvadori S
and Regoli D: Pharmacology of nociceptin and its receptor: a novel
therapeutic target. Br J Pharmacol. 129:1261–1283. 2000.PubMed/NCBI
|
23
|
Fox DA and Burks TF: Roles of central and
peripheral mu, delta and kappa receptors in the mediation of
gastric acid secretory effects in the rat. J Pharmacol Exp Ther.
244:456–462. 1988.PubMed/NCBI
|
24
|
Improta G and Broccardo M: Effect of
selective mu 1, mu 2 and delta 2 opioid receptor agonists on
gastric functions in the rat. Neuropharmacology. 33:977–981. 1994.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Osinski MA and Brown DR: Orphanin
FQ/nociceptin: a novel neuromodulator of gastrointestinal function.
Peptides. 21:999–1005. 2000. View Article : Google Scholar : PubMed/NCBI
|
26
|
Li HY, Yan X, Xue QL, et al: Effects of
nociceptin/orphanin FQ on rats with cathartic colon. World J
Gastroenterol. 13:141–145. 2007. View Article : Google Scholar : PubMed/NCBI
|
27
|
Broccardo M, Guerrini R, Petrella C and
Improta G: Gastrointestinal effects of intracerebroventricularly
injected nociceptin/orphaninFQ in rats. Peptides. 25:1013–1020.
2004. View Article : Google Scholar : PubMed/NCBI
|
28
|
Takahashi T, Mizuta Y and Owyang C:
Orphanin FQ, but not dynorphin A, accelerates colonic transit in
rats. Gastroenterology. 119:71–79. 2000. View Article : Google Scholar : PubMed/NCBI
|
29
|
Kunkel EJ, Campbell JJ, Haraldsen G, et
al: Lymphocyte CC chemokine receptor 9 and epithelial
thymus-expressed chemokine (TECK) expression distinguish the small
intestinal immune compartment: Epithelial expression of
tissue-specific chemokines as an organizing principle in regional
immunity. J Exp Med. 192:761–768. 2000. View Article : Google Scholar
|
30
|
Alemayehu A, Lock KR, Coatney RW and Chou
CC: L-NAME, nitric oxide and jejunal motility, blood flow and
oxygen uptake in dogs. Br J Pharmacol. 111:205–212. 1994.
View Article : Google Scholar : PubMed/NCBI
|
31
|
Kamel HM, Willmott N, McNicol AM and Toner
PG: The use of electron microscopy and immunocytochemistry to
characterise spontaneously-arising, transplantable rat tumors.
Virchows Arch B Cell Pathol Incl Mol Pathol. 57:11–18. 1989.
View Article : Google Scholar : PubMed/NCBI
|
32
|
Looi LM, Yap SF and Cheah PL: Correlation
between oestrogen receptor protein expression in infiltrating
ductal carcinoma of the breast by immunohistochemistry and cytosol
measurements. Ann Acad Med Singap. 26:750–753. 1997.
|
33
|
Ford AC, Talley NJ, Schoenfeld PS, Quigley
EM and Moayyedi P: Efficacy of antidepressants and psychological
therapies in irritable bowel syndrome: systematic review and
meta-analysis. Gut. 58:367–378. 2009. View Article : Google Scholar : PubMed/NCBI
|
34
|
Ohman L and Simrén M: Pathogenesis of IBS:
role of inflammation, immunity and neuroimmune interactions. Nat
Rev Gastroenterol Hepatol. 7:163–173. 2010. View Article : Google Scholar : PubMed/NCBI
|
35
|
Lü N, Han M, Yang ZL, Wang YQ, Wu GC and
Zhang YQ: Nociceptin/orphanin FQ in PAG modulates the release of
amino acids, serotonin and norepinephrine in the rostral
ventromedial medulla and spinal cord in rats. Pain. 148:414–425.
2010.PubMed/NCBI
|
36
|
Yazdani A, Takahashi T, Bagnol D, Watson
SJ and Owyang C: Functional significance of a newly discovered
neuropeptide, orphanin FQ, in rat gastrointestinal motility.
Gastroenterology. 116:108–117. 1999. View Article : Google Scholar : PubMed/NCBI
|